drugset
drugset / Trial / NCT05046262

Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

NCT05046262 ↗

Phase 3 Unknown 25 enrolled Bispebjerg Hospital Mirai Medical, Ireland · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation

Timeline

Start
2020-01-08
Primary completion
2022-02-22
Completion
2022-02-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium Chloride Unknown — —

Indications

basal cell carcinoma